HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection.

Salim I. Khakoo*, Chloe L. Thio, Maureen P. Martin, Collin R. Brooks, Xiaojiang Gao, Jacquie Astemborski, Jie Cheng, James J. Goedert, David Vlahov, Margaret Hilgartner, Steven Cox, Ann Margeret Little, Graeme J. Alexander, Matthew E. Cramp, Stephen J. O'Brien, William M.C. Rosenberg, David L. Thomas, Mary Carrington

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Natural killer (NK) cells provide a central defense against viral infection by using inhibitory and activation receptors for major histocompatibility complex class I molecules as a means of controlling their activity. We show that genes encoding the inhibitory NK cell receptor KIR2DL3 and its human leukocyte antigen C group 1 (HLA-C1) ligand directly influence resolution of hepatitis C virus (HCV) infection. This effect was observed in Caucasians and African Americans with expected low infectious doses of HCV but not in those with high-dose exposure, in whom the innate immune response is likely overwhelmed. The data strongly suggest that inhibitory NK cell interactions are important in determining antiviral immunity and that diminished inhibitory responses confer protection against HCV.
Original languageEnglish
Pages (from-to)872-874
Number of pages0
JournalScience
Volume305
Issue number5685
DOIs
Publication statusPublished - 6 Aug 2004

Keywords

  • Adolescent
  • Adult
  • Black or African American
  • Alleles
  • Blood Transfusion
  • Child
  • Cohort Studies
  • Female
  • HLA-C Antigens
  • Hepacivirus
  • Hepatitis C
  • Homozygote
  • Humans
  • Killer Cells
  • Natural
  • Ligands
  • Male
  • Receptors
  • Immunologic
  • KIR
  • KIR2DL1
  • KIR2DL3
  • Regression Analysis
  • White People

Fingerprint

Dive into the research topics of 'HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection.'. Together they form a unique fingerprint.

Cite this